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 Diagnosis of infection after total hip replacement is known to be difficult. Isolation of 
the bacterial pathogen can give false negative results with current culture methods. Molecular-
based methods, as Polymerase Chain Reaction (PCR), may help detect bacteria where culture 
fails; however, contamination with bacterial DNA when using universal bacterial primers has 
for a long time been a recognized problem. In this study we describe our attempts of 
designing a new, rapid PCR method for detection of bacteria in synovial fluid.  
During the development of this method both the QIAamp® DNA Mini Kit and the MagNA 
Pure LC Microbiology Kit MGRADE was tested for its extraction reliability. 
Hundred and fifteen synovial fluid samples were analysed for Staphylococcus aureus and 
methicillin-resistant staphylococci DNA, using the nuc and mecA gene respectively. The 
synovial fluids were also tested with universal bacterial primers and probe. The PCR results 
were then compared to the standard culture results. 
This study shows that culture for S.aureus and methicillin-resistant staphylococci was 
concordant with the results for nuc and mecA PCR. The universal PCR protocol detects more 
bacteria (58%) than the culturing method, but also presents many inconclusive results difficult 
to interpret. In our protocol the MagNA Pure LC Microbiology Kit MGRADE showed to be 
more reliable as DNA-extraction method.  
Our goal in this study was to develop a better and more reliable diagnostic method for the 
complicated hip replacement infections. The protocol shows the high potentials of the 
molecular-based methods, but the bacterial DNA contamination issues using broad-range 




In hip arthroplasty, diagnosis of infection is still an unsolved problem. Uniform 
criteria for the diagnosis of infection have not been established [1]. Almost half a million total 
hip and knee arthroplasties are annually performed worldwide [2]. Most patients restore full 
function, but a few per cent suffers post-operative complications. The main reasons for 
arthroplasty failure are aseptic loosening, infection and osteolysis [3]. These complications 
are often difficult to treat, with long term pain and discomfort for the patients. The small, but 
significant number of patients suffering from an undetected infection will not receive proper 
treatment and face chronic hip failure. The calculated cost of each total hip arthroplasty 
revision varies from US$ 5 600 to 28 700 [4].  
Aseptic loosening is a diagnosis of exclusion, and the aetiology is unknown [5] [6]. 
Clarke et al [7] showed in their study that tissue samples taken from arthroplasties considered 
to be aseptically loose implants, contained significantly more often bacterial DNA than their 
controls. Unfortunately they had contamination issues giving the study high rates of false-
positives (21%). 
 
 The current method to isolate the etiologic agent is culturing of aspirated joint fluid or 
tissue obtained at revision. Culturing can be insensitive and time-consuming [8]. The method 
depends on the etiologic agent and the specimens that are submitted for culture. Multiple 
specimens should be obtained and rapidly cultured in appropriate media. One suspects that 
biofilm, few bacteria, fastidious, slow growing and/or anaerobic microorganisms, extended 
transportation, inadequate preservation and antibiotic treatment all take part in causing false 
negative culturing results [6]. 
The spectrum of microbial agents capable of causing prosthetic joint infection is unlimited, 
the most common referred in table 1. The spectrum also includes organisms ordinarily 
considered ”contaminants” of cultures, such as corynebacteria, propionebacteia, and Bacillus 
spp. Rarely have infections with fungi (particularly Candida) or mycobacteria been described 
[9]. 
 
 In data collected by the Norwegian arthroplasty register aseptic loosening was 
recognized as the primary cause of revision [3]. After starting a more aggressive antibiotic 
treatment during surgery, the aseptic loosening rate also went down, suggesting that low grade 
infection is the primary cause, and often misclassified as aseptic loosening. 
 
 Polymerase Chain Reaction (PCR) is now emerging as a diagnostic tool of great value 
in bacterial detection [10]. PCR has successfully detected nonculturable bacteria in a variety 
of infections, such as meningitis [11] and septic arthritis [12]. Molecular-based methods, as 
PCR, bring hope where culture fails. The resent development in the PCR-technology is the 
real-time PCR which is time saving and less exposed to carryover contamination. 
Researchers worldwide are currently trying to develop new molecular methods to decrease 
detection time and increase assay sensitivity in arthroplasty infections. The well preserved 
DNA sequence of the eubacterial 16S rRNA gene has been used to secure detection of all 
bacteria. PCR can amplify extremely low levels of bacterial DNA to detectable levels, making 
it in theory, a perfect method for the low-grade hip infections.  
Several problems in reaching this goal have, however, been described, in particular problems 




 Bacterial DNA is everywhere. The highly sensitive PCR-technique with its enormous 
amplification power gives this sensitive method high potential, but also demands full sterility. 
Every known decontamination method has been tested, including UV-irradiation, filtering, 8-
MOP-treatment and incubation with various enzymes [10] [13]. None of these have yet 
convinced as a bacterial DNA contamination problem solving method. 
 
 In this study we describe our experiences with the attempt to establish a PCR method 
for detection of bacteria in hip replacement infections. We have tested decontamination 
methods described as successful and different PCR protocols attempting to detect only the 




Material and methods 
 
 Patients. Hundred-and six patients who underwent one or more revision hip 
arthroplasty from 1996-2002 was included in the study. The group of patients consisted of 78 
women and 28 men, with a mean age of 72.5 years (range, 31-96 years). Reasons for revision 
surgery included infection, suspicion of infection, mechanical failure (aseptic loosening) and 
osteolysis. 
 
 Sample collection. Hundred-and fifteen synovial fluid samples from 106 patients was 
collected per-operative in an ultra sterile, laminar air flow equipped operating theatre. The 
samples were drawn after exposing the hip joint and before opening the hip capsule and 
collected on 3 ml standard EDTA-tubes which were retrospectively analyzed for bacterial 
DNA. Until PCR testing the samples were stored at -70 °C. From all revisions, at least 3 




 Culturing. All revisions samples were cultured for common bacteria using standard 
techniques and protocols at the Department of Microbiology, Ulleval University Hospital, 
Oslo, Norway. Bacterial culture included aerobic and anaerobic protocol. For aerobic culture 
chocolate agar and enrichment were used and the cultures were incubated in 5% carbon 
dioxide at 35ºC for 7 days. The anaerobic culture was cultured at 35ºC for 5 days. 3 samples 
were not anaerobic cultured. 
 Culture of revision samples where defined as positive if the same bacteria were found 
in at least 2 different samples. In most cases, more than 5 revision samples were taken for 
culture, including synovial fluid where this was abundant. 34 synovial fluids were cultured 
aerobic and anaerobic, 10 only aerobic. Synovial fluids with minimum three revisions 
samples for culturing were included in the study, as recommended by Zimmerli, Trampuz et 
al [1]. 
 
 Bacterial strains. The species and American Type Culture Collection (ATCC) of 19 
common pathogenic microorganisms (Table 2) were grown in standard cultures, and genomic 
DNA was extracted using the QIAamp® DNA Mini Kit (Qiagen, GmbH, Germany) as 
described below. 
 
DNA extraction. Genomic DNA was extracted from synovial fluid specimens using 
QIAamp® DNA Mini Kit, following Protocol D with some modification. Bacterial cell pellet 
from 300 µl fluids was resuspended in a combination of 20 mg/ml lysozyme and 0.2 mg/ml 
lysostaphin (Sigma-Aldrich Co., St.Louis, MO, USA) solution and incubated for 1 hour at 
37oC to ensure complete lysis of all bacterial cells. Finally, the elution step was performed by 
adding 100 µl molecular biology reagent water (Sigma-Aldrich Co) and incubated for 5 min 
to increase DNA yield. To check for cross-contamination of samples during DNA extraction 
and bacterial DNA contamination of the reagents, negative controls were included after every 
second clinical sample. These negative controls consisted of sterile phosphate-buffered saline 
(PBS) and were handled in the same way as the patient samples. 
Bacterial DNA from some of the samples was also extracted using MagNA Pure LC 
Microbiology Kit MGRADE (Roche Applied Science, Penzberg, Germany) according to the 
manufacturer´s instructions, with some modifications. To ensure the highest possible 
sensitivity, bacterial cells were first pelleted from 100 - 600 µl synovial fluid, most of the 
supernatant was then discarded and the concentrated material and lysis buffer mix including 
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proteinase K was incubated for 30 min instead of 10 min. The MGRADE reagents are designed 
to perform isolation of highly purified bacterial genomic DNA from a variety of sample 
materials. They are tested for bacterial and fungal DNA contamination and no such 
contamination was detected. One negative DNA extraction control for every seventh clinical 
sample was included in every run. 
To validate the DNA extraction procedure, a positive control prepared from one 
S.aureus culture positive synovial fluid sample was treated exactly as patient sample in each 
run. Special precautions were taken to avoid bacterial DNA contamination and carry over 
contamination [14]. DNA samples were stored at -70˚C until real-time PCR analysis. 
 
 TaqMan real-time PCR assay. Amplification and detection of S. aureus and 
methicillin-resistant staphylococci DNA by PCR were performed with the Smart Cycler 
thermal cycler (Cepheid, Sunnyvale, Calif.). The TaqMan real-time PCR assay has been 
designed as a multiplex analysis of nuc gene and mecA gene simultaneously using primers 
and probes (Table 3), and was synthesized by Eurogentec (Seraing, Belgium). The optimized 
PCR master mixture using the qPCR™Core Kit (Eurogentec) consisted of  300 nM of each 
primer, 200 nM of each probe, 4 mM MgCl2, 0.4mM of each of the four dNTPs, 1.25 U of 
Hot GoldStar DNA polymerase, and 5 µl purified DNA in a total volume of 25 µl. The PCR 
cycling conditions included an initial denaturation step of 95ºC for 600 s followed by 40 
cycles of 95ºC for 15 s and 60ºC for 1 min. The amplification mixture and a water blank used 
to prepare the reagents, and DNA extracted from methicillin-resistant S. aureus (MRSA) were 
included in every run as negative and positive PCR control, respectively.  
The universal bacterial forward primer sequence was the reverse complement of the 
reverse primer described by Nadkarni et al [15] with some modifications (Table 3). The 
reverse primer and probe sequences (Table 3) were as described by Yang S et al [10]. The 
universal bacterial PCR assay was performed in a total volume of 25 µl containing 5 µl DNA 
extract, 200 nM of each primer and 150 nM of the probe (Eurogentec), and TaqMan Universal 
PCR Master Mixture (Applied Biosystems, Foster City, CA), including the enzyme uracil-N-
glycosylase (UNG) to prevent carryover contamination from previous amplifications. The 
amplification and detection of DNA were performed in an ABI PRISM 7000 Sequence 
Detection System (Applied Biosystems). The PCR cycling conditions were 50ºC for 2 min 
and 95ºC for 10 min, followed by 40 cycles of  95ºC for 15 s and 60ºC for 1 min. To test the 
PCR reaction mixture itself for contamination of bacterial DNA, four negative controls 
consisting of amplification mixture and sterile water instead of DNA template was included in 
each PCR.  
 Duplicate samples were routinely used for the real-time PCR assays and the presence 
of amplified products was confirmed when the fluorescent signal exceeded an automatic 
noise-based defined threshold (Ct). 
Using QIAamp as DNA extraction method, the definition of positive, inconclusive, and 
negative results were as follows: 
Positive: Ct<[(Ctmin of negative DNA extraction controls) – 2SD] 
Negative: Ct>[(Ctmean for negative DNA extraction controls) – 2SD] 
Inconclusive: [(Ctmin of negative DNA extraction controls) – 2SD]<Ct<[(Ctmean for negative 
DNA extraction controls) – 2SD] 
 
Using MagNA Pure LC Microbiology Kit MGRADE as DNA extraction method, the definition 







 Detection of S. aureus and methicillin-resistant staphylococci DNA by real-time 
PCR. DNA was extracted from 115 synovial fluids using the QIAamp® DNA Mini Kit and 
analysed for the nuc gene and mecA gene simultaneously. The protocol correctly detected all 
positive controls and no false positive signals were detected in the no-template controls. Four 
culture-positive S.aureus samples where all nuc PCR positive. None of the culture-negative 
specimens was PCR positive. One sample was mecA PCR positive. This bacterium was 
identified as Staphylococcus epidermidis by culture and reported as methicillin-resistant. 
 
 Detection of bacteria using QIAamp® extraction procedure and universal 
bacterial real-time PCR. Our PCR protocol was first assessed with genomic DNA extracts 
from 19 bacterial species commonly causing infections. All 19 bacterial species were detected 
by the universal bacterial real-time PCR (Table 2). 
Extracted DNA from the 115 synovial fluids and controls were then run with universal 
primers and probe to detect the presence of any eubacterial DNA. This protocol detected all 
the positive controls, but also gave positive results for the no-template controls. 
By this method bacteria were detected in all of the samples which were positive by culture 
and in seven of the culture-negative samples. This broad-range PCR protocol gave many 
results difficult to interpret, with many samples in a grey zone between positive and negative 
(referred to as inconclusive). Of these, 2 was culture positive, 36 was culture negative, and 1 
was inconclusive (Table 4). 
 
 Detection of bacteria using MGRADE extraction procedure and universal bacterial 
real-time PCR. The samples with enough synovial fluid left (67 samples) were finally used 
for DNA isolation with the MagNA Pure LC Microbiology Kit MGRADE, and run with the 
universal bacterial PCR protocol. This protocol correctly detected all positive controls, and no 
controls were false positive. 
The results from the two different DNA extraction procedures were finally compared with 








 Contamination is a well known problem in bacterial detection using broad-range PCR. 
PCR is in theory capable of detecting one single copy of template DNA, making the demands 
for sterility difficult to maintain. In addition, the use of the highly preserved 16S rRNA-gene 
includes all bacteria. This creates a conflict between the desire to apply this enormous 
sensitive capacity, and the difficulties in detecting only the true pathogenous bacteria in a 
clinical sample. 
 
 Our samples were probably not contaminated during harvesting to a great extent. 
Samples were taken under ultra-sterile conditions in the operating theatre, after incision of the 
skin, but before opening of the joint capsule. Thus the operation had only lasted less than 5 
minutes, and the chances of contamination of instruments and the operating field should be 
minimal compared to samples taken later in the revision (for instance from removed parts of 
the prosthesis itself which may take one hour or more). 
 
 We also experienced difficulties in eliminating bacterial DNA contamination in 
reagents used for PCR. To overcome this problem we tested several described successfull 
decontamination methods to destroy DNA when optimizing our PCR protocol. This included 
UV irradiation of the Taq-polymerase for various times, and prefiltration of the PCR mix 
prior to the addition of template-DNA using Amicon Microcon YM-100 centrifugal filter 
device ( Millipore Co, Bedford, Mass). We also tested a “clean” Taq-polymerase (Ampli Taq 
LD, Applied Biosystems). It was not possible in this study to eliminate endogenous 
contaminating DNA from the PCR mixture with these methods without seriously 
compromising the efficiency of the PCR (data not shown). 
 
 Synovial fluid is an intricate, protein-rich material consisting of proteoglycans which 
makes the digestion of hydrolytic enzymes ineffective. It also contains inhibiting factors 
which can interfere with the PCR and it can be extremely viscose making the extraction and 
centrifugation difficult. When the synovial fluid is infected, the fluid becomes even more 
complex, making the process of using synovial fluid even more challenging [2].  
 
 With this knowledge of synovial fluid in mind we felt the need to control our DNA 
extraction using the QIAamp® DNA Mini Kit. The samples, some of them who were 
confirmed culture-positive with S.aureus, were therefore run with our standardized 
methicillin-resistant S.aureus-PCR to ensure true positive results.  
 
 Our results show that the nuc and mecA PCR successfully predicted the presence of 
respectively S.aureus and methicillin-resistant staphylococci in all samples. In this study the 
PCR results were concordant with the culture results and gave the results within 4 hours, 
compared with 2-3 days for the culturing. This corresponds with other studies on methicillin-
resistant PCR-assays [16, 17]. It is important to be aware that in this PCR, detection of the 
mecA gen is not in conjunction with the S.aureus-specific genom fragment - the nuc gen. 
Therefore it is not possible to distinguish the presence of methicillin-resistent S. aureus 
(MRSA) from mecA positive strains of coagulase-negative staphylococcus spp (CNS) in 
samples containing both S.aureus and CNS. 
 
We ended up using the TaqMan Universal PCR mix and molecular biology reagent water 
(Sigma-Aldrich Co) as negative PCR controls which gave successful results for these negative 
controls. However, after the extraction step with QIAamp® DNA Mini Kit, many negative 
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DNA extraction controls turned positive, rising suspicions of contamination with bacterial 
DNA in the QIAamp kit. This is concordant with other studies [18]. This further gave too 
many positive PCR results for the samples, making a cut-off of the Ct-values necessary.  
 
 Because of these problems with the QIAamp kit we tested the accessible samples 
again with the MagNA Pure LC Microbiology Kit MGRADE. Using this DNA isolation kit no 
false positive negative extraction controls was observed, and so in this study, the MagNA 
Pure LC Microbiology Kit MGRADE showed to be more reliable as extraction method. 
 
 Several studies operates with a detection threshold of the number of bacteria per cubic 
centimetre [7, 19]. The studies use different thresholds, making comparisons difficult. Clarke 
et al (2004) concludes that no conclusive data exist to indicate the level at which the detection 
threshold should be set. Our concern is that when choosing a threshold and thus reducing the 
sensitivity, one excludes samples with extreme low levels of bacteria. We do not yet know 
how low levels of bacteria are capable of causing the infections we are trying to find. In our 
study, we therefore do not operate with a detection threshold.  This made the study vulnerable 
to laboratory-based false positive results. 
 
 The same problems arise when interpreting the universal PCR results. What Ct-values 
reflect correctly the shift between the low grade infections and the laboratory-based false 
positive results? More research is needed to make this gap between true low-grade infections 
and false background DNA results smaller. In this study our universal bacterial PCR detected 
bacteria in all of the samples which were positive by culture and in 58% (7 of 12) of the 
culture-negative samples (Table 4). The PCR-positive, culture-negative samples are unlikely 
to be positive due to contaminating bacterial DNA, as the criteria for positive samples were 
very stringent to make sure these samples were true positives. Our result verifies the suspicion 
that culturing does not detect all true pathogens. 
Thirty-six samples found negative by culture gave PCR results within the “grey zone”. The 
total number of samples within the grey-zone by PCR was 41 of 115. Is this due to 
background DNA and contamination problems only, or is this group (also) containing true 
low-grade infections? With culture as the golden standard this question can still not be 
answered. 
 With our protocol none of the negative PCR results were culture-positive, indicating 
that the PCR protocol and cut off points used were adequate. 
In this study synovial fluids with minimum three revision samples for culturing were included 
in the material. Zimmerli et al recommends that at least three intraoperative tissue specimens 
should be sampled for culturing [1]. We also defined culture positive samples as growth of the 
same bacteria in at least 2 different samples. This low number of samples in addition to the 
stringent positive criteria makes the interpretation of the results vulnerable. One can suspect a 
higher rate of false negative results with these criteria, and perhaps this contributes to the gap 
between the PCR and culture results.  
 
 Several other similar studies use other clinical examinations available to assist in 
predicting a diagnosis. In this study, we chose to only record the culture results, and not the 
other examinations available to make a diagnosis. Blood tests, isotope scanning, gram’s 
staining, histological analysis and culturing are all currently in use to diagnose the infections. 
The role and usefulness of each test have been reviewed, but no test, or set of tests, have 
showed required specificity and sensitivity to be considered reliable [1]. Histopathological 
findings vary with the different infections, depending on the type of  bacteria, the duration of 
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the infection and whether the infection is polymicrobial [20]. The histopathological findings 
also give poor sensitivity, especially in cases of low-grade infections [21]. 
 
 The clinical use of the PCR-techniques in near future will probably be with specific 
primers and probes when suspecting specific bacteria with high risk of complications, such as 
with the methicillin-resistant bacteria, where rapid and reliable detection is crucial. MecA-
PCR will provide a rapid answer for the bacterial sensitivity to penicillinase stable penicillins. 
Culturing can not be fully replaced with these methods. The detection of the resistance 
patterns will still be important to identify the bacterial sensitivity to different antimicrobial 
drugs. Perhaps will a combination of the two methods solve the problems with the detection 
of hip revision infections?  
With PCR, antibiotic treatment will not affect the PCR-result because this technique is not 
dependent on in vitro growth of the organism. Thus one can start, or continue, antibiotic 
therapy while samples are taken and the assay is analysed. This is important especially when 
identifying highly pathogenic bacteria which can give life threatening infections. 
           This study gave no negative PCR results on the culture-positive samples. This gives 
the protocol a potential as a rapid detection of true “non-infected”. This can be a valuable 
result when the other tests, such as CRP and ESR are inconclusive. Because of the short 
analysing time one can thus assume that the protocol can be useful as part of a preoperative 
assessment. 
 
 Our goal in this study was to develop a better and more reliable diagnostic method for 
the complicated hip replacement infections. The contamination issues prove this goal yet 
difficult to achieve and more research is needed to overcome this obstacle. Until the problems 
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Table 1. Bacteriology of prosthetic joint infection, 
pathogens and frequency (%) a
 
 
Coagulase-negative staphylococci  22% 
Staphylococcus aureus   22% 
Viridans streptococci   9% 
Beta-hemolytic streptococci gr A, B, G 5% 
Enterococci     7% 
Gram-negative aerobic bacilli  25% 
Anaerobes     10% 
 
   aMandell, G.L., et al., Mandell, Douglas, and Bennett's 
principles and practice of infectious diseases - 5th ed. 2000.
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Table 2. Bacterial species detected by the TaqMan real-time PCR using the universal probe 




Bacterial species Isolate type or 
ATCC no. 
Streptococcus pyogenes 19615 
β-hem streptococci Clinical isolate 
Staphylococcus epidermidis 12228 
Enterococcus faecalis 51299 
Streptococcus pneumoniae 49619 
Haemophilus influenzae Clinical isolate 
Neisseria meningitidis Clinical isolate 
Staphylococcus aureus Clinical isolate 
Streptococcus sanguis  Clinical isolate 
Propionibacterium acnes Clinical isolate 
Bacillus subtilis 6633 
Klebsiella pneumoniae 700603 
Enterobacter cloacae Clinical isolate 
Serratia marcescens Clinical isolate 
Pseudomonas aeruginosa Clinical isolate 
Streptococcus oralis Clinical isolate 
Escherechia coli 12900 
Klebsiella oxytoca Clinical isolate 



























































Table 4 Comparison of universal bacterial real-time PCRa with culturing
 
 




















































a using QIAamp® as extraction method 
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Table 5 Evaluation of two different DNA-extraction methodsa, using universal bacterial real-






















































































a MagNA Pure LC Microbiology Kit MGRADE and QIAamp® DNA Mini Kit (Qiagen). 
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